Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium

NCT00082719 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Urethral Cancer

Interventions

BIOLOGICAL: Recombinant Interferon Alfa

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]